体检B超发现盆腔实性包块,无症状....

2019-08-25 不详 影像园

体检B超发现盆腔实性包块,无症状....

【所属科室】

普外科

【基本资料】

男,30岁

【主诉】

体检B超发现盆腔实性包块,无症状

【影像图片】













【讨论】

评论:盆腔内见以类圆形软组织密度影,边缘清楚,密度均匀,周围肠腔稍受压变形,增强后病灶呈均匀性强化;盆腔内未见明显肿大淋巴结;余未见明显异常。间质瘤?
 
【病理结果】

病理结果:副脾

【病例小结】

副脾是一种并不少见的先天性变异,是存在于正常脾脏以外,与正常脾脏结构相似、功能相同的组织,其发生可能因胚胎期始基芽融合不全或异位脾芽形成,或部分脾组织脱落主脾块发育而成,并具有单独的动、静脉。

副脾多位于脾门、脾蒂或脾尾部位,少数出现于脾、脾结肠韧带、大网膜及其他部位。本例副脾位于盆腔内,较为少见,易误诊为肠系膜或腹膜来源的病变。如果全腹部、盆腔同时行平扫并增强扫描的话,通过对比观察正常脾脏的强化方式、程度,并测量CT值变化情况,不失为一个鉴别的好办法。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1771587, encodeId=385c1e71587e8, content=<a href='/topic/show?id=1937334448f' target=_blank style='color:#2F92EE;'>#包块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33444, encryptionId=1937334448f, topicName=包块)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3638322754, createdName=qidongfanjian, createdTime=Sat Jul 18 22:51:00 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305182, encodeId=a3d01305182e0, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485041, encodeId=39861485041c5, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618681, encodeId=98bf1618681fe, content=<a href='/topic/show?id=232f3859c9' target=_blank style='color:#2F92EE;'>#B超#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3859, encryptionId=232f3859c9, topicName=B超)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57019929498, createdName=ms7524819409032184, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1771587, encodeId=385c1e71587e8, content=<a href='/topic/show?id=1937334448f' target=_blank style='color:#2F92EE;'>#包块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33444, encryptionId=1937334448f, topicName=包块)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3638322754, createdName=qidongfanjian, createdTime=Sat Jul 18 22:51:00 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305182, encodeId=a3d01305182e0, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485041, encodeId=39861485041c5, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618681, encodeId=98bf1618681fe, content=<a href='/topic/show?id=232f3859c9' target=_blank style='color:#2F92EE;'>#B超#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3859, encryptionId=232f3859c9, topicName=B超)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57019929498, createdName=ms7524819409032184, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]
    2019-08-27 marongnuan
  3. [GetPortalCommentsPageByObjectIdResponse(id=1771587, encodeId=385c1e71587e8, content=<a href='/topic/show?id=1937334448f' target=_blank style='color:#2F92EE;'>#包块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33444, encryptionId=1937334448f, topicName=包块)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3638322754, createdName=qidongfanjian, createdTime=Sat Jul 18 22:51:00 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305182, encodeId=a3d01305182e0, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485041, encodeId=39861485041c5, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618681, encodeId=98bf1618681fe, content=<a href='/topic/show?id=232f3859c9' target=_blank style='color:#2F92EE;'>#B超#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3859, encryptionId=232f3859c9, topicName=B超)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57019929498, createdName=ms7524819409032184, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1771587, encodeId=385c1e71587e8, content=<a href='/topic/show?id=1937334448f' target=_blank style='color:#2F92EE;'>#包块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33444, encryptionId=1937334448f, topicName=包块)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d3638322754, createdName=qidongfanjian, createdTime=Sat Jul 18 22:51:00 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305182, encodeId=a3d01305182e0, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485041, encodeId=39861485041c5, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618681, encodeId=98bf1618681fe, content=<a href='/topic/show?id=232f3859c9' target=_blank style='color:#2F92EE;'>#B超#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3859, encryptionId=232f3859c9, topicName=B超)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57019929498, createdName=ms7524819409032184, createdTime=Tue Aug 27 04:51:00 CST 2019, time=2019-08-27, status=1, ipAttribution=)]